Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2270-2280
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2270
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2270
Screening stage | Progressive tumors (%, 95%CI) | Colonoscopy group/FIT group | |||
Colonoscopy group | FIT group | Graded screening group | OR (95%CI) | P value | |
Baseline screening | |||||
Overall | 2.76 (2.29-3.32) | 0.15 (0.94-1.42) | 0.65 (1.39-1.96) | 2.45 (1.84-3.26) | < 0.001 |
Proximal colon | 1.36 (1.05-1.78) | 0.53(0.39-0.71) | 0.62 (0.47-0.83) | 2.62 (1.74-3.97) | < 0.001 |
Distal colon and rectum | 1.73 (1.36-2.19) | 0.80 (0.62-1.02) | 0.17 (0.95-1.43) | 2.19 (1.54-3.12) | < 0.001 |
Baseline screening + 1st follow-up screening | |||||
Overall | 2.76 (2.29-3.32) | 0.67 (1.41-1.98) | 0.91 (1.63-2.24 | 1.68 (1.29-2.18) | < 0.001 |
Proximal colon | 1.36 (1.05-1.78) | 0.72 (0.55-0.95) | 0.73 (0.56-0.94) | 1.91 (1.30-2.79) | 0.001 |
Distal colon and rectum | 1.73 (1.36-2.19) | 1.15 (0.94-1.42 | 1.35 (1.12-1.63) | 0.50 (1.08-2.06) | 0.014 |
Baseline screening + 1st follow-up screening + 2nd follow-up screening | |||||
Overall | 2.76 (2.29-3.32) | 2.17 (1.87-2.52) | 2.35 (2.04-2.71) | 0.30 (1.01-1.65) | 0.037 |
Proximal colon | 1.36 (1.05-1.78) | 0.96 (0.77-1.20) | 0.90 (0.71-1.13) | 1.46 (1.05-2.05) | 0.031 |
Distal colon and rectum | 1.76 (1.45-2.18) | 1.48 (1.23-1.77) | 1.65 (1.39-1.96) | 1.19 (0.88-1.61) | 0.244 |
Screening stage | Colonoscopy group compared to grading screening group | Graded screening group/FIT group | |||
OR (95%CI) | P value | OR (95%CI) | P value | ||
Baseline screening | |||||
Overall | 1.69 (1.29-2.20) | < 0.001 | 1.45 (1.11-1.92) | 0.008 | |
Proximal colon | 2.21 (1.49-3.28) | 0.001 | 1.19 (0.79-1.82) | 0.409 | |
Distal colon and rectum | 1.46 (1.06-2.02) | 0.021 | 1.49 (1.08-2.08) | 0.017 | |
Baseline screening + 1st follow-up screening | |||||
Overall | 1.45 (1.12-1.87) | 0.004 | 1.15 (0.91-1.47) | 0.245 | |
Proximal colon | 1.9 (1.29-2.76) | 0.001 | 1.01 (0.70-1.47) | 0.941 | |
Distal colon and rectum | 1.26 (0.92-1.72) | 0.148 | 1.18 (0.88-1.57) | 0.266 | |
Baseline screening + 1st follow-up screening + 2nd follow-up screening | |||||
Overall | 1.19 (0.93-1.51) | 0.156 | 1.09 (0.88-1.34) | 0.440 | |
Proximal colon | 1.56 (1.10-2.20) | 0.012 | 0.94 (0.68-1.29) | 0.681 | |
Distal colon and rectum | 1.06 (0.79-1.42) | 0.680 | 1.12 (0.87-1.44) | 0.384 |
- Citation: Xu M, Yang JY, Meng T. Effectiveness of colonoscopy, immune fecal occult blood testing, and risk-graded screening strategies in colorectal cancer screening. World J Gastrointest Surg 2024; 16(7): 2270-2280
- URL: https://www.wjgnet.com/1948-9366/full/v16/i7/2270.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i7.2270